Taxus Cardium Pharmaceuticals Price on December 19, 2024
CRXMDelisted Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Taxus Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Taxus Cardium stands at 0.0001, as last reported on the 24th of December, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Taxus Cardium Pharmaceuticals, which you can use to evaluate the volatility of the company.
Taxus Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Taxus |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CRXM |
Based on monthly moving average Taxus Cardium is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Taxus Cardium by adding Taxus Cardium to a well-diversified portfolio.
Related Headline
Acasti Pharma Headline on 25th of October 2024
Acasti Pharma changes name to Grace Therapeutics by seekingalpha.com
Acasti Pharma changes its name to Grace Therapeutics, set to trade as GRCE on Nasdaq starting October 28, 2024.
Taxus Cardium Valuation on December 19, 2024
It is possible to determine the worth of Taxus Cardium on a given historical date. On December 19, 2024 Taxus was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Taxus Cardium pink sheet. Still, in general, we apply an absolute valuation method to find Taxus Cardium's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Taxus Cardium where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Taxus Cardium's related companies.
Open | High | Low | Close | Volume | |
12/24/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.00 |
Backtest Taxus Cardium | | | Taxus Cardium History | | | Taxus Cardium Valuation |
Taxus Cardium Trading Date Momentum on December 19, 2024
Taxus Cardium Pharma Fundamentals Correlations and Trends
By evaluating Taxus Cardium's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Taxus Cardium's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Taxus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Taxus Cardium Pink Sheet history
Taxus Cardium investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Taxus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Taxus Cardium Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Taxus Cardium stock prices may prove useful in developing a viable investing in Taxus Cardium
Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. Gene Biotherapeutics, Inc. was incorporated in 2003 and is headquartered in San Diego, California. Taxus Cardium operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Taxus Cardium Pink Sheet Technical Analysis
Taxus Cardium technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Taxus Cardium Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Taxus Cardium Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Taxus Cardium December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Taxus Cardium pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Taxus Cardium shares will generate the highest return on investment. By undertsting and applying Taxus Cardium pink sheet market strength indicators, traders can identify Taxus Cardium Pharmaceuticals entry and exit signals to maximize returns
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Taxus Pink Sheet
If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Transaction History View history of all your transactions and understand their impact on performance |